REFERENCES Bagnstoss, A. H, and Rosenberg, E. F. (1941). Arch. intern. Med., 67. 241. Bauer, W., and Clark, W. S. (1948). Trans. Ass. Amer. Phycns, 61, 339. Bennett, G. A. (1943). Ann. Intern. Med., 19, lIt. Bywaters, E. G. L. (1950). Brit. Heart J., 12, 101. Clar, W. S., Kulka, J. P., and Bauer, W. (1957). Amer. J. Med., 22, 580. Dubois, E. L. (1953). Ann. intern. Med., 38, 1265. Fingerman, D....

Ann Rheum Dis March 2010 Vol 69 No 3 473 1Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada 2Erasmus Medical Centre, University of Rotterdam, Rotterdam, The Netherlands Correspondence to: Dr Vivian P Bykerk, Mount Sinai, 75 Francis Street, PBB-B3, Boston, MA 02115, USA; [email protected] When does rheumatoid arthritis start and can it be stopped before it does? Vivian P B...

In this paper, a novel flow injection chemiluminescence (FI-CL) method is proposed for the determination of picomolar L(-1) levels of hydrogen peroxide (H(2)O(2)) in exhaled breath condensate (EBC). This method is based on the oxidation of a low concentration of luminol (10(-7) M) by H(2)O(2) at a low concentration level (< 10(-8) M) in an alkaline medium catalyzed by a complex, K(5)[Cu(HIO(6))...

1 Minden K, Niewerth M, Listing J et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2392–401. 2 Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. J Am Med Assoc 2005;294:1671–84. 3 Cortis E, Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr 2006;95(Suppl.):38–41. 4 Cohen SB, Emery P, ...

arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 2004;22:416–20. 25. Minaur N, Sawyers S, Parker J, Darmawan J. Rheumatic disease in an Australian aboriginal community in north Queensland, Australia. A WHO-ILAR COPCORD survey. J Rheumatol 2004;31:965–72. 26. Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:589–604. 27. Gabriel SE, Crowson CS,...

Twelve clinical trials have documented that prednisone or prednisolone in doses of 10 mg/day or less is efficacious to improve function, maintain status and/or slow radiographic progression in patients with rheumatoid arthritis (RA). An early trial reported by de Andrade et al. [Ann Rheum Dis 1964; 23: 158–162] in 1964 indicated that 5 mg of prednisolone at night was preferred to 5 mg of predni...

Twelve clinical trials have documented that prednisone or prednisolone in doses of 10 mg/day or less is efficacious to improve function, maintain status and/or slow radiographic progression in patients with rheumatoid arthritis (RA). An early trial reported by de Andrade et al. [Ann Rheum Dis 1964;23:158-162] in 1964 indicated that 5 mg of prednisolone at night was preferred to 5 mg of predniso...